Published in Biotech Business Week, December 25th, 2006
Co-promotion agreements open the doors to Europe and enable companies with little or no European presence to effectively reach physicians and patients and successfully launch new products.
U.S.-based drug makers are finding commercial success with product co- promotion agreements, which is a quick and efficient way to promote new drugs in markets where companies do not have the necessary sales and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.